IFNB1 and Brain atrophy: In clinical trials, effects of IFN-β on general brain atrophy as indirect evidence for neuroprotection have been described [27], however, these effects were inconsistently seen for different formulations of IFN-β and reflect the sum of various tissue changes such as oedema resolution or demyelination.